Company Filing History:
Years Active: 2024
Title: Fakhri B Saida: Innovator in Antibody Assay Technologies
Introduction
Fakhri B Saida is a notable inventor based in San Diego, CA. He has made significant contributions to the field of immunology, particularly in the analysis of neutralizing antibodies related to SARS-CoV-2. His work is crucial in understanding and combating coronavirus infections.
Latest Patents
Fakhri B Saida holds 1 patent for his invention titled "Compositions and methods for assaying neutralizing antibodies." This patent provides compositions and methods for analyzing neutralizing antibodies to SARS-CoV-2 in samples from subjects suspected of having, having had, or having recovered from a SARS-CoV-2 infection. The invention also addresses subjects who have received prophylactic or therapeutic interventions for coronavirus infections.
Career Highlights
Fakhri B Saida is currently associated with Diazyme Laboratories, Inc., where he applies his expertise in developing innovative solutions for antibody analysis. His work at Diazyme Laboratories has positioned him as a key player in the fight against viral infections.
Collaborations
Some of his notable coworkers include Chong-Sheng Yuan and Abhijit Datta, who collaborate with him on various projects aimed at advancing research in immunology and antibody assays.
Conclusion
Fakhri B Saida's contributions to the field of antibody analysis are invaluable, particularly in the context of the ongoing pandemic. His innovative approaches and collaborations continue to enhance our understanding of neutralizing antibodies and their role in combating viral infections.